JPH0768272B2 - ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤 - Google Patents

ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤

Info

Publication number
JPH0768272B2
JPH0768272B2 JP2-504271A JP50427190A JPH0768272B2 JP H0768272 B2 JPH0768272 B2 JP H0768272B2 JP 50427190 A JP50427190 A JP 50427190A JP H0768272 B2 JPH0768272 B2 JP H0768272B2
Authority
JP
Japan
Prior art keywords
cells
tcf
human
activity
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2-504271A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0768272B1 (es
JPWO1990010651A1 (ja
Inventor
侃二 東尾
伸二郎 満田
伸行 島
康治 板垣
雅哉 永尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26340889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0768272(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of JPWO1990010651A1 publication Critical patent/JPWO1990010651A1/ja
Publication of JPH0768272B1 publication Critical patent/JPH0768272B1/ja
Publication of JPH0768272B2 publication Critical patent/JPH0768272B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2-504271A 1989-03-10 1990-03-09 ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤 Expired - Lifetime JPH0768272B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP1-58631 1989-03-10
JP5863189 1989-03-10
JP2-6692 1990-01-16
JP669290 1990-01-16
PCT/JP1990/000314 WO1990010651A1 (en) 1989-03-10 1990-03-09 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP6218183A Division JP2747979B2 (ja) 1994-08-19 1994-08-19 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
JP8191458A Division JPH0925297A (ja) 1996-07-01 1996-07-01 ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤

Publications (3)

Publication Number Publication Date
JPWO1990010651A1 JPWO1990010651A1 (ja) 1991-02-07
JPH0768272B1 JPH0768272B1 (es) 1995-07-26
JPH0768272B2 true JPH0768272B2 (ja) 1995-07-26

Family

ID=26340889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2-504271A Expired - Lifetime JPH0768272B2 (ja) 1989-03-10 1990-03-09 ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤

Country Status (17)

Country Link
US (2) US5587359A (es)
EP (1) EP0462277B1 (es)
JP (1) JPH0768272B2 (es)
KR (1) KR960009054B1 (es)
AT (1) ATE123498T1 (es)
AU (1) AU629314B2 (es)
CA (1) CA2049017C (es)
DE (1) DE69019962T2 (es)
DK (1) DK0462277T3 (es)
ES (1) ES2075199T3 (es)
FI (1) FI102681B (es)
HU (2) HU212513B (es)
IE (1) IE64005B1 (es)
NO (1) NO180796C (es)
NZ (1) NZ232813A (es)
RU (1) RU2113480C1 (es)
WO (1) WO1990010651A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
DE69133492T2 (de) * 1990-06-11 2006-08-10 Nakamura, Toshikazu Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
DE69131069T2 (de) * 1990-07-13 1999-07-15 Snow Brand Milk Products Co., Ltd., Sapporo, Hokkaido Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
EP0571387B1 (en) * 1990-09-14 2003-12-17 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A non-mitogenic competitive hgf antagonist
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
JP3200609B2 (ja) * 1990-12-28 2001-08-20 敏一 中村 上皮細胞増殖促進剤
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
EP0653211B1 (en) * 1992-07-16 2001-10-17 Snow Brand Milk Products Co., Ltd. Blood coagulation normalizer containing tcf-ii as active ingredient
JP3380573B2 (ja) 1992-07-16 2003-02-24 第一製薬株式会社 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
KR100271087B1 (en) * 1992-07-16 2000-11-01 Snow Brand Milk Products Co Ltd Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
JPH07507328A (ja) * 1992-12-28 1995-08-10 雪印乳業株式会社 Ｔｃｆ変異体
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
JP2747979B2 (ja) * 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
ZA9510982B (en) * 1994-12-27 1996-08-22 Snow Brand Milk Products Co Ltd TCF mutant
JPH08176007A (ja) * 1994-12-27 1996-07-09 Snow Brand Milk Prod Co Ltd 脂質代謝異常治療剤
JP3927248B2 (ja) * 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
AU4027601A (en) * 1995-07-11 2001-07-26 Snow Brand Milk Products Co., Ltd. Lyophilized HGF preparations
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CN100417412C (zh) * 2003-03-28 2008-09-10 威海赛洛金药业有限公司 促肝细胞生长素注射液及制备方法和应用
CA2537246A1 (en) * 2003-09-03 2005-03-17 Kringle Pharma Inc. Skin ulcer preventive or curative agent containing human recombinant hgf
RU2520817C2 (ru) * 2006-01-25 2014-06-27 Октафарма Аг Очистка и применение фактора, способствующего заживлению ран
WO2008136183A1 (ja) * 2007-04-28 2008-11-13 Applied Cell Biotechnologies, Inc. 皮膚または歯肉の軟組織の欠損を補修するための組成物，及び自己線維芽細胞の培養方法
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
JP5579164B2 (ja) * 2008-04-09 2014-08-27 ビロメッド カンパニー， リミテッド 凍結乾燥ｄｎａ製剤、組成物、及び凍結乾燥ｄｎａ製剤を製造する方法
US10639351B2 (en) 2013-10-22 2020-05-05 Helixmith Co., Ltd. Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
CN106456695B (zh) * 2014-04-28 2019-11-12 卫材R&D管理有限公司 Hgf的冻干配制品
WO2016039163A1 (ja) 2014-09-10 2016-03-17 クリングルファーマ株式会社 神経疾患の治療に適したｈｇｆ製剤
KR102275262B1 (ko) 2016-03-17 2021-07-12 에자이 알앤드디 매니지먼트 가부시키가이샤 활성 간세포 성장 인자(hgf)를 생성하는 방법
KR20210027493A (ko) 2018-07-19 2021-03-10 주식회사 헬릭스미스 네이키드 dna 유전자 요법을 위한 동결 건조된 약제학적 조성물
EP4574211A3 (en) 2021-05-14 2025-09-10 Claris Biotherapeutics, Inc. Compositions of growth factor for the treatment of eye disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58148826A (ja) * 1982-02-26 1983-09-05 Mochida Pharmaceut Co Ltd 糖蛋白質および腫瘍治療剤
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE3643182A1 (de) * 1986-12-18 1988-06-30 Behringwerke Ag Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
JPS6410998A (en) * 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
JPH0741891B2 (ja) * 1987-08-26 1995-05-10 凸版印刷株式会社 容器素材成形装置
FI80741C (fi) * 1987-10-29 1990-07-10 Laennen Tehtaat Oy Modifierat papper.
DE69131069T2 (de) * 1990-07-13 1999-07-15 Snow Brand Milk Products Co., Ltd., Sapporo, Hokkaido Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung

Also Published As

Publication number Publication date
AU5177490A (en) 1990-10-09
HU212513B (en) 1996-07-29
EP0462277A4 (en) 1992-08-12
IE900863L (en) 1990-09-10
NO913546D0 (no) 1991-09-09
CA2049017A1 (en) 1990-09-11
HU211229A9 (en) 1995-11-28
RU95110767A (ru) 1997-06-10
EP0462277B1 (en) 1995-06-07
ES2075199T3 (es) 1995-10-01
FI102681B1 (fi) 1999-01-29
KR920701256A (ko) 1992-08-11
US5587359A (en) 1996-12-24
RU2113480C1 (ru) 1998-06-20
ATE123498T1 (de) 1995-06-15
US6333309B1 (en) 2001-12-25
KR960009054B1 (ko) 1996-07-10
DE69019962D1 (de) 1995-07-13
NO180796C (no) 1997-06-25
JPH0768272B1 (es) 1995-07-26
HUT58797A (en) 1992-03-30
AU629314B2 (en) 1992-10-01
FI914234A0 (fi) 1991-09-09
NZ232813A (en) 1992-08-26
NO180796B (no) 1997-03-17
WO1990010651A1 (en) 1990-09-20
HU902330D0 (en) 1991-12-30
EP0462277A1 (en) 1991-12-27
IE64005B1 (en) 1995-06-28
NO913546L (no) 1991-11-11
DE69019962T2 (de) 1995-11-23
DK0462277T3 (da) 1995-10-30
CA2049017C (en) 1998-10-27
FI102681B (fi) 1999-01-29

Similar Documents

Publication Publication Date Title
JPH0768272B2 (ja) ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤
US5607918A (en) Vascular endothelial growth factor-B and DNA coding therefor
AU729880B2 (en) Recombinant vascular endothelial cell growth factor D (VEGF-D)
JP2634323B2 (ja) Ｔｃｆ‐▲ｉｉ▼のアミノ酸配列をコードするｄｎａを含むプラスミド，形質転換細胞及びこれを用いて生理活性物質を生産する方法
Shi et al. A novel cytokine receptor-ligand pair: identification, molecular characterization, and in vivo immunomodulatory activity
JPWO1990010651A1 (ja) ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤
EP0416578B1 (en) Protein, DNA and use thereof
Yamauchi et al. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells
Howard et al. Complementary DNA and derived amino acid sequence of the. beta. subunit of human complement protein C8: identification of a close structural and ancestral relationship to the. alpha. subunit and C9
CA2084514A1 (en) O-glycosylated ifn-alpha
AU638402B2 (en) Analogs of fibroblast growth factor
JPWO1992001053A1 (ja) Ｔｃｆ‐２のアミノ酸配列をコードするｄｎａを含むプラスミド，形質転換細胞及びこれを用いて生理活性物質を生産する方法
EP0859009B1 (en) Recombinant human hepatocyte growth factor and method for production thereof
CA2134030C (en) Soluble interferon .alpha.-receptor, its preparation and use
JP2747979B2 (ja) ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
Nguyen et al. Isolation of a biologically active soluble human interferon-α receptor-GST fusion protein expressed in Escherichia coli
JPH08140683A (ja) 新規な白血球活性化因子
US20070212390A1 (en) Protease-resistant forms of VEGF-D, method of making and method of use
EP0948618A1 (en) HUMAN POLYHOMEOTIC 2($i(hph2)) ACTS AS AN ONCOGENE
JPH0925297A (ja) ヒト由来の糖蛋白質及び該糖蛋白質からなる生理活性因子とそれを活性成分とする製剤
JPH10316582A (ja) 血管細胞調節剤
US20040006210A1 (en) Human polyhomeotic 2 (hph2) acts as an oncogene
SK5402001A3 (en) Prv-1 gene and the use thereof
CA2233367A1 (en) Short forms of chemokine .beta.-8
JPH03123487A (ja) 新規ポリペプチドの製造法